cb-012
caribou
['cb-012', 'cll', 'caribou']
caribou biosciences presents new preclinical data on cb-012, an allogeneic anti-cll-1 car-t cell therapy, at the 2023 aacr annual meeting | caribou biosciences, inc. 
All in on $BEAM and $NTLA. Looking for 8x in 4-4.5 years (3/26/23). Believe BEAM can become most valuable #biotech in the world 🌎 #CRISPR #longevity